{"DataElement":{"publicId":"5286039","version":"1","preferredName":"Cancer Patient Tobacco Use Questionnaire 15 Past 30 Days Products Used to Quit or Stay Off Smoking Cigarettes Type","preferredDefinition":"A person's stated observation of the products they have used to quit or to stay off smoking cigarettes in the past 30 days.","longName":"CTUQ_Q15_TYPE","context":"PS-CC","contextVersion":"1","DataElementConcept":{"publicId":"5285553","version":"1","preferredName":"Cancer Patient Tobacco Use Questionnaire Products Used to Quit or Stay Off Smoking Cigarettes Past 30 Days","preferredDefinition":"A questionnaire developed for the baseline and longitudinal assessment of tobacco use in the cancer setting. Domains include cigarette smoking history and current use, use relative to cancer diagnosis and treatment, other tobacco product use, cessation, and second-hand exposure._A question about the products an individual used in the past 30 days to quit or stay off smoking cigarettes.","longName":"5285223v1.0:5285551v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"5285223","version":"1","preferredName":"Cancer Patient Tobacco Use Questionnaire","preferredDefinition":"A questionnaire developed for the baseline and longitudinal assessment of tobacco use in the cancer setting. Domains include cigarette smoking history and current use, use relative to cancer diagnosis and treatment, other tobacco product use, cessation, and second-hand exposure.","longName":"C127024","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Patient Tobacco Use Questionnaire","conceptCode":"C127024","definition":"A questionnaire developed for the baseline and longitudinal assessment of tobacco use in the cancer setting. Domains include cigarette smoking history and current use, use relative to cancer diagnosis and treatment, other tobacco product use, cessation, and second-hand exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"346071B8-1140-3785-E050-BB89AD4306CC","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5285551","version":"1","preferredName":"Products Used to Quit or Stay Off Smoking Cigarettes Past 30 Days","preferredDefinition":"A question about the products an individual used in the past 30 days to quit or stay off smoking cigarettes.","longName":"C127094","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Products Used to Quit or Stay Off Smoking Cigarettes Past 30 Days","conceptCode":"C127094","definition":"A question about the products an individual used in the past 30 days to quit or stay off smoking cigarettes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3461CE9A-F047-336D-E050-BB89AD4331B5","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C-TUQ:Cancer Patient Tobacco Use Questionnaire. NCI-AACR Cancer Patient Tobacco Use Assessment Task Force, 6/19/2015","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3461CE9A-F058-336D-E050-BB89AD4331B5","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"COOPERM","dateModified":"2016-09-23","changeDescription":"Created for Study in Rave as requested by S.Land. mc 6/3/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5285211","version":"1","preferredName":"Quit Cigarette Product Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"QUIT_CIG_PROD_TYPE","context":"PS-CC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Varenicline (Chantix)","valueDescription":"Varenicline Tartrate","ValueMeaning":{"publicId":"3276674","version":"1","preferredName":"Varenicline Tartrate","longName":"3276674","preferredDefinition":"A drug used to help people stop smoking by acting the same way nicotine acts in the brain. It is a type of nicotine receptor partial agonist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Varenicline Tartrate","conceptCode":"C61998","definition":"A drug used to help people stop smoking by acting the same way nicotine acts in the brain. It is a type of nicotine receptor partial agonist.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-958F-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"348C7168-AD9C-05C7-E050-BB89AD43019B","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-05","modifiedBy":"ONEDATA","dateModified":"2016-06-05","deletedIndicator":"No"},{"value":"Nicotine nasal spray","valueDescription":"Nicotine Nasal Spray","ValueMeaning":{"publicId":"3276680","version":"1","preferredName":"Nicotine Nasal Spray","longName":"3276680","preferredDefinition":"A nasal spray composed of an aqueous solution containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the spray into the nostrils, nicotine is taken up from the nasal mucosa into the bloodstream. Although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Nasal Spray","conceptCode":"C16162","definition":"A nasal spray composed of an aqueous solution containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the spray into the nostrils, nicotine is taken up from the nasal mucosa into the bloodstream. Although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9601-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A889-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Nicotine inhaler","valueDescription":"Nicotine Inhaler","ValueMeaning":{"publicId":"3276682","version":"1","preferredName":"Nicotine Inhaler","longName":"3276682","preferredDefinition":"A device consisting of a mouthpiece and a thin, plastic cartridge that contains nicotine plug and delivers nicotine in a vapor that is absorbed in the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Inhaler","conceptCode":"C19977","definition":"A device consisting of a mouthpiece and a thin, plastic cartridge that contains nicotine plug and delivers nicotine in a vapor that is absorbed in the mouth.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-9627-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A894-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Nicotine lozenge","valueDescription":"Nicotine Lozenge","ValueMeaning":{"publicId":"3276678","version":"1","preferredName":"Nicotine Lozenge","longName":"3276678","preferredDefinition":"A lozenge preparation containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the lozenge, nicotine is released and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Lozenge","conceptCode":"C90531","definition":"A lozenge preparation containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the lozenge, nicotine is released and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-95DB-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A89F-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Nicotine gum","valueDescription":"Nicotine Gum","ValueMeaning":{"publicId":"3276683","version":"1","preferredName":"Nicotine Gum","longName":"3276683","preferredDefinition":"A chewing gum containing nicotine used as a substitute for the active ingredient in tobacco. Nicotine chewing gum reduces the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Gum","conceptCode":"C15663","definition":"A chewing gum containing nicotine used as a substitute for the active ingredient in tobacco. Nicotine chewing gum reduces the withdrawal symptoms associated with smoking cessation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACFBB39A-964C-633A-E040-BB89AD436C25","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A8AA-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Nicotine patch","valueDescription":"Nicotine Patch","ValueMeaning":{"publicId":"5285213","version":"1","preferredName":"Nicotine Patch","longName":"5285213","preferredDefinition":"A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly released into the bloodstream and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nicotine Patch","conceptCode":"C17955","definition":"A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly released into the bloodstream and, although nicotine binds to nicotinic cholinergic receptors at the autonomic ganglia, adrenal medulla and at neuromuscular junctions as well, the binding of nicotine to the receptors in the central nervous system (CNS) appears to be responsible for the addictive nature of nicotine. Binding to CNS nicotinic acetylcholine receptors causes the release of the neurotransmitter dopamine which appears to be responsible for the addiction of nicotine. Administration of nicotine may prevent nicotine craving and may help with the withdrawal symptoms associated with smoking cessation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"345FC402-A8B5-DE13-E050-BB89AD434D33","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A8CE-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"E-cigarettes or other electronic nicotine delivery system","valueDescription":"Electronic Cigarette","ValueMeaning":{"publicId":"5285179","version":"1","preferredName":"Electronic Cigarette","longName":"5285179","preferredDefinition":"A battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation in a manner that simulates smoking a tobacco cigarette.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electronic Cigarette","conceptCode":"C120482","definition":"A battery-powered electronic device designed to atomize a nicotine-containing liquid solution for inhalation in a manner that simulates smoking a tobacco cigarette.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"345959FC-E06A-A3D4-E050-BB89AD431060","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A8D8-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A8E2-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Other, Please specify:","valueDescription":"Specify Other","ValueMeaning":{"publicId":"4888051","version":"1","preferredName":"Specify Other","longName":"4888051","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"195A90B1-87F5-D292-E050-BB89AD432B03","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"345FC402-A8EC-DE13-E050-BB89AD434D33","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"ONEDATA","dateModified":"2016-06-03","deletedIndicator":"No"},{"value":"Bupropion (Wellbutrin, Zyban)","valueDescription":"Bupropion","ValueMeaning":{"publicId":"5285212","version":"1","preferredName":"Bupropion","longName":"5285212","preferredDefinition":"An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown.  This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bupropion","conceptCode":"C62012","definition":"An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown.  This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"345FC402-A866-DE13-E050-BB89AD434D33","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"348C7168-AD88-05C7-E050-BB89AD43019B","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-05","modifiedBy":"ONEDATA","dateModified":"2016-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"C-TUQ:Cancer Patient Tobacco Use Questionnaire. NCI-AACR Cancer Patient Tobacco Use Assessment Task Force, 6/19/2015","workflowStatus":"RELEASED","registrationStatus":"Application","id":"345FC402-A838-DE13-E050-BB89AD434D33","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"COOPERM","dateModified":"2016-08-10","changeDescription":"Created for Study in Rave as requested by S.Land. mc 6/3/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2193114","version":"1","longName":"Division of Cancer Control and Population Sciences","context":"PS-CC","ClassificationSchemeItems":[{"publicId":"5285152","version":"1","longName":"C-TUQ (Cancer Patient Tobacco Use Questionnaire)","context":"PS-CC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"C-TUQ Question Sequence","type":"Measure Sequence Number","description":"33 of 47","url":null,"context":"PS-CC"},{"name":"In the past 30 days, what, if","type":"Preferred Question Text","description":"In the past 30 days, what, if any, products have you used to quit (or to stay off) smoking cigarettes?","url":null,"context":"PS-CC"},{"name":"Check all that apply.","type":"NOTE","description":"Check all that apply.","url":null,"context":"PS-CC"},{"name":"Using PRO/HRQoL Measures","type":"Outcome Measure Implementation","description":"This data element is part of a full set of items that comprise a PRO/HRQoL measure. The full set must be used without any changes to the questions or value sets in order to retain the validity and reliability associated with the measure. Changes may not be made to these CDEs.","url":null,"context":"PS-CC"}],"origin":"C-TUQ:Cancer Patient Tobacco Use Questionnaire. NCI-AACR Cancer Patient Tobacco Use Assessment Task Force, 6/19/2015","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3479A12A-BF73-64AA-E050-BB89AD43281C","latestVersionIndicator":"Yes","beginDate":"2016-06-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-04","modifiedBy":"SBR","dateModified":"2016-09-23","changeDescription":"Created for Study in Rave as requested by S.Land. mc 6/4/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}